Norwest Venture Partners XI

Latest statistics and disclosures from Norwest Venture Partners XI's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are HCAT, and represent 100.00% of Norwest Venture Partners XI's stock portfolio.
  • Reduced shares in these 1 stock: HCAT (-$54M).
  • Norwest Venture Partners XI was a net seller of stock by $-54M.
  • Norwest Venture Partners XI has $32M in assets under management (AUM), dropping by -53.27%.
  • Central Index Key (CIK): 0001534522

Tip: Access up to 7 years of quarterly data

Positions held by Norwest Venture Partners XI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Norwest Venture Partners XI

Norwest Venture Partners XI holds 1 positions in its portfolio as reported in the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Health Catalyst (HCAT) 100.0 $32M -62% 876k 36.60
 View chart

Past Filings by Norwest Venture Partners XI

SEC 13F filings are viewable for Norwest Venture Partners XI going back to 2013